Skip to main content
. 2021 Apr 27;59(2):85–89. doi: 10.5114/reum.2021.105416

Table I.

Comparisons between patients with and without a final diagnosis of celiac disease

Variable CD group (n = 4) Non-CD group (n = 126) p-value
Symptoms, n (%)
 Diarrhea 3 (75) 9 (7.1) < 0.001
 Constipation 1 (25) 6 (4.8) 0.077
 Fatigue 2 (50) 19 (15) 0.062
 Weight loss 1 (25) 11 (8.7) 0.268
 Dyspepsia 4 (100) 36 (28.6) 0.002
 Nausea/vomiting 1 (25) 4 (3.2) 0.025
 Abdominal pain 3 (75) 30 (23.8) 0.021
 Bloating 2 (50) 20 (15.9) 0.073
 Recurrent oral aphthosis 4 (100) 11 (8.7) < 0.001
 Atopy 1 (25) 0 (0) < 0.001
Laboratory tests
 Positive AEA, n (%) 4 (100) 1 (0.8) < 0.001
 Positive AGA, n (%) 2 (50) 2 (1.6) < 0.001
 HLA-DQ2, n (%) 1 (25) 4 (3.2) 0.025
 HLA-DQ8, n (%) 4 (100) 9 (7.1) < 0.001
 Total IgA [mg/dl] 230.5 130.2 0.049
 ESR [mm/h] 20.67 10.99 0.023
 CRP [mg/l] 11.33 4.69 0.028
 Creatinine [mg/dl] 1.03 1 0.6
 Hb [g/dl] 9.87 11.88 0.004
 Platelets [count/mm3] 206 × 103 193 × 103 0.418

Statistically significant comparisons are indicated in bold. AEA – anti-endomysium antibodies, AGA – anti-gliadin antibodies, CD – celiac disease, CRP – C-reactive protein, ESR – erythrocyte sedimentation rate, Hb – hemoglobin, HLA – human leukocyte antigen.